Spring To Life 2014
The goal of this activity is to bring together cancer care providers and members of the community—including patients and their caregivers—to gain an up-to-date understanding of blood cancers, including the state-of-the-art science behind them, their clinical management, ongoing translational research, and emerging therapies. The program will also provide perspectives on the impact cancer has on the lives of patients and families.
This conference will focus on multi-disciplinary care for patients with an acute leukemia. Specifically, clinician sessions will detail evidence-based treatment standards for acute leukemias, optimal use of multimodality treatments, current controversies in the field, and ongoing translational and clinical studies. The conference will partner national experts, community practitioners, and members of the community in order to enhance understanding and collaboration between these groups, and to foster better care for and communication with patients with hematologic malignancies.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and MedEd Consulting, LLC. The Mecical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.0 hours of participation for continuing education for allied health professionals.
The target audience for this conference is family and primary care practitioners, hematologists, oncologists, pediatricians, allied health professionals (including nurses, pharmacists, and social workers), basic scientists, and members of the community (including patients and their family and caregivers).
- Apply the knowledge gained regarding the science and clinical management of acute leukemias to improve patient care
- Critically evaluate and integrate emerging data related to acute leukemias
- Discuss what is known about the effectiveness of therapies for the acute leukemias, including the appropriate role and timing of bone stem cell transplantation
- Apply strategies to enhance coordination of care for patients with acute leukemias
- Communicate the benefits and harms of each medical option to patients with an acute leukemia, and their families/caregivers, while engaging in shared decision making
- Collaborate in and optimize holistic supportive care through enhanced understanding of the leukemia experience on patients, families, and caregivers (primary care and ancillary health care providers)
Melissa Cochran, MD
Daniel DeAngelo, MD
Laurie Malone, MD
Courtney Bellomio, MD
Sami Brake, MD
Edward Dick, LCSW
R. Coleman LIndsley, MD
All persons in control of content have NO relevant financial relationships to disclose.
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved:
Ira Zackon, MD Millenium Pharmaceuticals
Vikramjit Kanwar, MD Jazz Pharmaceuticals
Robert Soiffer, MD Takeda, GlaxoSmithKline & Fresenius
- 4.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.00 Hours of ParticipationHours of Participation credit.